Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of customer service provider LivePerson (NASDAQ: LPSN ) plummeted 34% today after its quarterly results and outlook disappointed Wall Street.
So what: LivePerson's first-quarter revenue rose a solid 16%, but a bottom-line miss -- adjusted EPS of $0.06 versus the consensus of $0.07 -- coupled with the loss of a major client is forcing analysts to seriously lower their valuation estimates. While the client's exit represents a lost revenue stream of just $5 million, it could be a more serious sign of waning demand for real-time assistance.
Now what: Management now sees full-year adjusted EPS of $0.18-$0.21 on revenue of $174 million-$179 million, well below the consensus of $0.32 and $183.8 million. "We're adjusting full year guidance based on the full year impact of Q1 attrition and the softening European market and increased investment necessary for the additional resources behind sales marketing and R&D to support the rollout of the LiveEngage platform," said CFO Daniel Murphy on a conference call. Of course, when you couple today's massive plunge with LivePerson's still-solid financial position -- $95 million in cash and no debt -- the downside might be limited enough to take a closer look. �
Top Defensive Companies To Own In Right Now: Seanergy Maritime Holdings Corp (SHIP)
Seanergy Maritime Holdings Corp., through its subsidiaries, provides seaborne transportation of dry bulk commodities. As of May 7, 2013, the company�s fleet consisted of 7 drybulk carriers, including 2 Panamax, 2 Supramax, and 3 Handysize vessels with a total carrying capacity of approximately 326,255 dwt. Its fleet carries various dry bulk commodities, including coal, iron ore, and grains, as well as bauxite, phosphate, fertilizer, and steel products. Seanergy Maritime Holdings Corp. was founded in 2008 and is based in Athens, Greece.
Advisors' Opinion:- [By Rebecca McClay]
And dry bulk shippers like FreeSeas Inc. (Nasdaq: FREE), Seanergy Maritime Holdings Corp. (Nasdaq: SHIP), and Eagle Bulk Shipping Inc. (Nasdaq: EGLE) are noting big gains today as shipping rates strengthen. FREE is up 8%, SHIP is up 13%, and EGLE is up 7% as capesize shipping rates increased overnight by about 10%, exceeding $20,000 for the first time since January 2012.
- [By Roberto Pedone]
Another stock that looks poised to trigger a near-term breakout trade is Seanergy Maritime (SHIP), which provides transportation solutions in the dry bulk shipping sector through its vessel-owning subsidiaries for a range of dry bulk cargoes, including coal, iron ore, and grains, bauxite, phosphate and steel products. This stock has been red hot so far in 2013, with shares up a whopping 63%.
If you take a look at the chart for Seanergy Maritime, you'll notice that this stock has just started to spike back above both its 50-day and 200-day moving averages with above-average volume. In fact, volume for SHIP over the last few weeks has been showing bullish flows as the stock has flirted with those key moving averages. This move is quickly pushing shares of SHIP within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in SHIP if it manages to break out above some near-term overhead resistance at $1.74 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 12,297 shares. If that breakout hits soon, then SHIP will set up to re-test or possibly take out its next major overhead resistance levels at $2.06 to $2.09 a share. Any high-volume move above those levels will then put $2.19 to its 52-week high at $2.71 into range for shares of SHIP.
Traders can look to buy SHIP off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $1.44 a share. One could also buy SHIP off strength once it takes out $1.74 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top Managed Healthcare Companies For 2014: Synopsys Inc (SNPS)
Synopsys, Inc., incorporated in 1986, is engaged in providing technology solutions used to develop electronics and electronic systems. It supplies the electronic design automation (EDA) software that engineers use to design, create prototypes for and test integrated circuits, also known as chips. It also supplies software and hardware used to develop the systems that incorporate integrated circuits and the software that runs on those integrated circuits. Its intellectual property (IP) products are pre-designed circuits that engineers use as components of larger chip designs rather than redesigning those circuits themselves. It also provides technical services to support its solutions and it help its customers develop chips and electronic systems. Its products and services are organized into four groups: Core EDA (which includes the Galaxy Design Platform, the Discovery Verification Platform and its Field Programmable Gate Array (FPGA) design products); IP and System-Level Solutions; Manufacturing Solutions and Professional Services. In July 2012, it acquired Ciranova. In October 2012, it acquired EVE. On November 30, 2012, the Company acquired SpringSoft. In February 2014, Synopsys Inc completed the acquisition of Target Compiler Technologies.
On September 2, 2010, the Company acquired Virage Logic Corporation. In October 2010, the Company acquired Optical Research Associates. In September 2011, the Company acquired nSys Design Systems Private Limited (nSys). In October 2011, the Company acquired Extreme DA. In January 2012, the Company acquired ExpertIO, Inc. In February 2012, the Company acquired Magma Design Automation Inc.
Core EDA products
The Company offers a number of Core EDA products to address the process. Its Core EDA products fall into the suites, which included the Galaxy Design Platform, which includes tools to design an integrated circuit; the Discovery Verification Platform, which includes tools to verify that an integrated circuit behaves! as intended, and the FPGA design products. Its Galaxy Design Platform provides its customers with a single, integrated chip design solution, which includes individual products and incorporates common libraries and consistent timing, delay calculation and constraints throughout the design process. The platform allows designers the flexibility to integrate internally-developed and third-party tools. With this advanced functionality, common foundation and flexibility, its Galaxy Design Platform reduces design times; decrease integration costs and minimize the risks inherent in advanced, integrated circuit designs. Its products span both digital and analog/mixed-signal designs.
The products included in the Galaxy Design Platform are the IC Compiler physical design solution, Design Compiler logic synthesis product, Galaxy Custom Designer physical design solution for analog/mixed-signal designs, PrimeTime/PrimeTime SI timing analysis products, StarRC product for extraction, and the Hercules and IC Validator physical verification product family. The Lynx Design System is a production-ready chip implementation environment that combines a Galaxy-based design flow, graphical user interface (GUI)-based runtime automation, design metrics capture and reporting, and utilities that automate the configuration of pre-validated foundry data. The Lynx Design System helps customers improve their productivity and optimally deploy Synopsys tools and methodologies.
The Company�� Discovery Verification Platform is an integrated portfolio of functional, analog/mixed-signal, formal and low-power verification products. The platform includes its simulation and verification products and design-for-verification methodologies, and provides a consistent control environment to help improve the speed, breadth and accuracy of its customers��verification efforts. The Discovery Verification Platform�� components support industry standards and span both digital and analog/mixed-signal designs. The principa! l product! s included in the Discovery Verification Platform are the VCS comprehensive RTL verification solution, Formality formal verification sign-off solution, NanoSim FastSPICE circuit simulation and analysis product, high-speed interface module (HSIM) hierarchical FastSPICE circuit simulation and analysis product, HSPICE circuit simulator, and CustomSim circuit simulation solution. FPGAs are chips that can be customized or programmed to perform a specific function after they are manufactured.
Intellectual Property (IP) and System-Level Solutions
Synopsys is a provider of high-quality, silicon-proven IP solutions for system-on-chip (SoC) designs. The broad DesignWare IP portfolio includes high quality solutions for widely used interfaces such as universal serial bus (USB), PCI Express, double data rate (DDR), Ethernet, serial advanced technology attachment (SATA) and high-definition multimedia interface (HDMI). In addition, Synopsys offers analog IP for high-definition video, analog-to-digital data conversion and audio. With its recent acquisition of Virage Logic Corporation, we added embedded memories, including static random access memory (SRAMs) and non-volatile memory, logic libraries, embedded test and repair IP and configurable processor cores, to its IP portfolio.
Synopsys has a portfolio of tools, models and services for the system-level design of SoCs. Primary system-level products include Platform Architect for architectural optimization, SPW and System Studio for algorithm design, Processor Designer for custom processor design, and Synphony Model and C Compiler for High Level Synthesis. In addition to these tools for the system-level design of SoCs, its portfolio includes prototyping tools for hardware verification, software development and hardware-software integration. With FPGA-based prototyping systems (HAPS), designers can speed embedded software development by three to six months with near real runtime speeds and real world interfaces, such as its pre-t! ested Des! ignWare IP components. The HAPS hardware systems are a modular, scalable and accurate way to model a chip. Its virtual prototyping solutions enable software engineers to start SoC and application software up to twelve months before traditional methods.
Manufacturing Solutions
The Company�� Manufacturing Solutions products and technologies address this problem by introducing manufacturability and yield considerations early in the design process, thereby improving yields. Some of its Manufacturing Solutions address mask-making and yield enhancement of very small-geometry integrated circuits, as well as high-level modeling of physical effects within the integrated circuit. Its Manufacturing Solutions include the Technology-CAD (TCAD) device modeling products, Proteus OPC optical proximity correction (OPC) products, CATS mask data preparation product and yield management solutions, including odyssey and recipe manager and editor (RME), and yield explorer.
Professional Services and Training
Synopsys provides consulting and design services that address all phases of the SoC development process. These services assist Synopsys customers with new tool and methodology adoption, chip architecture and specification development, functional and low power design and verification, and physical implementation and signoff. It also provides a range of expert training and workshops on its latest tools and methodologies.
Advisors' Opinion:- [By Anna Prior]
Synopsys Inc.'s(SNPS) fiscal fourth-quarter profit nearly doubled on a top-line increase driven by growth in the company’s time-based license revenue. However, the company’s guidance for the current quarter came in below Wall Street expectations.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Synopsys (Nasdaq: SNPS ) , whose recent revenue and earnings are plotted below.
Top Managed Healthcare Companies For 2014: Enzon Pharmaceuticals Inc. (ENZN)
Enzon Pharmaceuticals, Inc., a biotechnology company, engages in the research and development of therapeutics for cancer patients with unmet medical needs. The company?s drug-development programs utilize two platforms-Customized PEGylation Linker Technology and third-generation mRNA-targeting agents utilizing the Locked Nucleic Acid (LNA) technology. It currently holds four compounds in clinical development and multiple novel LNA targets in preclinical research. The company?s development product pipeline consists of PEG-SN38 compound that utilizes Customized Linker Technology, which is in Phase II clinical trials for the treatment of metastatic colorectal and breast cancer, as well as a Phase I trial for pediatric patients with cancer; and the Hypoxia-Inducible Factor-1 alpha antagonist in Phase I studies for the treatment of solid tumors and lymphoma. Its product line also comprises Survivin antagonist in Phase I study in pediatric patients with recurrent acute lymphoblas tic leukemia; Androgen Receptor antagonist, a validated target for the treatment of prostate cancer that is in a Phase I study in patients with castration-resistant prostate cancer; and rights to five compounds, including AR, HER3, beta-catenin, PI3KCA, and Gli2. Enzon Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Piscataway, New Jersey.
Advisors' Opinion:- [By Monica Wolfe]
Over the past week Seth Klarman (Trades, Portfolio) of The Baupost Group made one real time reduction; the guru reduced his holdings in Enzon Pharmaceutical (ENZN).� The guru cut his holdings in the company -43.6% by selling 3,353,595 shares of the company�� stock.� He sold these shares at an average price of $1.15 per share; the shares are still currently trading at around the same price.
- [By Lisa Levin]
Enzon Pharmaceuticals (NASDAQ: ENZN) shares fell 2.57% to touch a new 52-week low of $1.11. Enzon Pharmaceuticals shares have dropped 75.85% over the past 52 weeks, while the S&P 500 index has gained 24.92% in the same period.
Top Managed Healthcare Companies For 2014: Retractable Technologies Inc. (RVP)
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare industry in the United States and internationally. Its products include VanishPoint 0.5mL insulin syringes; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 2mL, 3mL, 5mL, and 10mL syringes; small diameter tube adapters; blood collection tube holder; allergy trays; IV safety catheters; Patient Safe syringes; Patient Safe Luer Caps; and VanishPoint blood collection set, as well as autodisable syringes. The company sells its products to healthcare providers, such as acute care hospitals, alternate care facilities, doctors� offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons. Retractable Technologies, Inc. distributes its products through a direct marketing network; and general line and specialty distributors, as well as through international distributors. The company was founded in 1994 and is headquartered in Little Elm, Texas.
Advisors' Opinion:- [By Holly LaFon]
Chip Skinner is a portfolio manager and principal of Royce & Associates, LLC, investment advisor to The Royce Funds. He serves as portfolio manager for Royce Value Plus Fund (RVP) and serves as an assistant portfolio manager for Royce Low-Priced Stock Fund (RLP). The thoughts expressed in this piece are solely those of the person speaking and may differ from those of other Royce investment professionals, or the firm as a whole. There can be no assurance with regard to future market movements.
Top Managed Healthcare Companies For 2014: Analytica Bio - Energy Corp (ABEC)
Analytica Bio-Energy Corp., formerly Uniwell Electronic Corporation, incorporated on January 12, 2004, is a company with water purification system. The Company was a shell company.
The Company focused on acquiring an active business. In September 2013, the Company changed its name to Analytica Bioenergy, Inc.
Advisors' Opinion:- [By Dan Burrows]
Most importantly, on days when this penny stock did see heavy volume, it tumbled — a classic red flag for the “dump” part of pump-and-dump schemes, which penny stocks are ripe for.
Top Penny Stocks: Analytica Bio-Energy Corp. (ABEC)YTD Performance: 29,300%
52-Week Range: $0.0017 – $0.50
Average Volume (3 months): 9,574
Market Cap: $10.6 million
No comments:
Post a Comment